183 related articles for article (PubMed ID: 1909048)
1. The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.
Hetland ML; Eldrup E; Bratholm P; Christensen NJ
Scand J Clin Lab Invest; 1991 May; 51(3):219-24. PubMed ID: 1909048
[TBL] [Abstract][Full Text] [Related]
2. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ
J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408
[TBL] [Abstract][Full Text] [Related]
3. New approaches to evaluate sympathoadrenal system activity in experiments on earth and in space.
Kvetnansky R; Noskov VB; Blazicek P; Macho L; Grigoriev AI; Goldstein DS; Kopin IJ
Acta Astronaut; 1994 Oct; 34():243-54. PubMed ID: 11540743
[TBL] [Abstract][Full Text] [Related]
4. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.
Pernow J; Lundberg JM; Kaijser L; Hjemdahl P; Theodorsson-Norheim E; Martinsson A; Pernow B
Clin Physiol; 1986 Dec; 6(6):561-78. PubMed ID: 3466738
[TBL] [Abstract][Full Text] [Related]
5. Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans.
Eisenhofer G; Brush JE; Cannon RO; Stull R; Kopin IJ; Goldstein DS
J Clin Endocrinol Metab; 1989 Feb; 68(2):247-55. PubMed ID: 2563731
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
Eisenhofer G; Goldstein DS; Stull R; Keiser HR; Sunderland T; Murphy DL; Kopin IJ
Clin Chem; 1986 Nov; 32(11):2030-3. PubMed ID: 3096593
[TBL] [Abstract][Full Text] [Related]
7. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.
Pernow J; Lundberg JM; Kaijser L
J Cardiovasc Pharmacol; 1988; 12(5):593-9. PubMed ID: 2468060
[TBL] [Abstract][Full Text] [Related]
8. Pattern of plasma levels of catecholamines in familial dysautonomia.
Axelrod FB; Goldstein DS; Holmes C; Berlin D; Kopin IJ
Clin Auton Res; 1996 Aug; 6(4):205-9. PubMed ID: 8902316
[TBL] [Abstract][Full Text] [Related]
9. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.
Morris MJ; Russell AE; Kapoor V; Cain MD; Elliott JM; West MJ; Wing LM; Chalmers JP
J Auton Nerv Syst; 1986 Oct; 17(2):143-9. PubMed ID: 3782722
[TBL] [Abstract][Full Text] [Related]
10. Increased cardiac production of dihydroxyphenylalanine (DOPA) during sympathetic stimulation in anaesthetized dogs.
Eisenhofer G; Smolich JJ; Esler MD
Neurochem Int; 1992 Jul; 21(1):37-44. PubMed ID: 1303141
[TBL] [Abstract][Full Text] [Related]
11. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release.
Takiyyuddin MA; Brown MR; Dinh TQ; Cervenka JH; Braun SD; Parmer RJ; Kennedy B; O'Connor DT
J Auton Pharmacol; 1994 Jun; 14(3):187-200. PubMed ID: 7929473
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
Koulu M; Scheinin M; Kaarttinen A; Kallio J; Pyykkö K; Vuorinen J; Zimmer RH
Br J Clin Pharmacol; 1989 Feb; 27(2):243-55. PubMed ID: 2469451
[TBL] [Abstract][Full Text] [Related]
13. Cardiac noradrenergic function one year following cardiac transplantation.
Rundquist B; Eisenhofer G; Dakak NA; Elam M; Waagstein F; Friberg P
Blood Press; 1993 Dec; 2(4):252-61. PubMed ID: 8173693
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover.
Eisenhofer G; Meredith IT; Ferrier C; Cox HS; Lambert G; Jennings GL; Esler MD
J Lab Clin Med; 1991 Apr; 117(4):266-73. PubMed ID: 1901341
[TBL] [Abstract][Full Text] [Related]
15. Circulating dihydroxyphenylglycol and norepinephrine concentrations during sympathetic nervous system activation in patients with pheochromocytoma.
Atuk NO; Hanks JB; Weltman J; Bogdonoff DL; Boyd DG; Vance ML
J Clin Endocrinol Metab; 1994 Dec; 79(6):1609-14. PubMed ID: 7989464
[TBL] [Abstract][Full Text] [Related]
16. [Simultaneous liquid chromatographic determination of plasma 3,4-dihydroxyphenylglycol and norepinephrine as indicators of sympathetic activity].
Okumura K; Ito T
Nihon Naibunpi Gakkai Zasshi; 1990 Nov; 66(11):1164-9. PubMed ID: 2286283
[TBL] [Abstract][Full Text] [Related]
17. Effects of ordinary meals on plasma concentrations of 3,4-dihydroxyphenylalanine, dopamine sulphate and 3,4-dihydroxyphenylacetic acid.
Eldrup E; Møller SE; Andreasen J; Christensen NJ
Clin Sci (Lond); 1997 Apr; 92(4):423-30. PubMed ID: 9176043
[TBL] [Abstract][Full Text] [Related]
18. Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans.
Goldstein DS; Cannon RO; Quyyumi A; Chang P; Duncan M; Brush JE; Eisenhofer G
J Auton Nerv Syst; 1991 Jun; 34(1):17-35. PubMed ID: 1940014
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man.
Edvinsson L; Ekman R; Thulin T
Regul Pept; 1991 Feb; 32(3):279-87. PubMed ID: 1866472
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous liquid chromatographic determination of norepinephrine, 3,4-dihydroxyphenylethyleneglycol, 3,4-dihydroxyphenylalanine and 3,4-dihydroxyphenylacetic acid in human plasma.
Premel-Cabic A; Allain P
J Chromatogr; 1988 Dec; 434(1):187-90. PubMed ID: 3149644
[No Abstract] [Full Text] [Related]
[Next] [New Search]
